Medicinal Products

Tritazide 2,5 mg/12,5 mg tablete

Name Tritazide 2,5 mg/12,5 mg tablete
Marketing Authorisation Number HR-H-290180500
Active Substance ramipril
hidroklorotiazid
Composition jedna tableta sadrži 2,5 mg ramiprila i 12,5 mg hidroklorotiazida
Pharmaceutical Form tableta
Manufacturer Sanofi S.r.l., Scoppito (L'Aquila), Italija
Marketing Authorisation Holder Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska
Marketing Authorisation Date 01.09.2023
MA Period of Validity unlimited
Classification Number UP/I-530-09/16-02/200
Registration Number 381-12-01/286-23-57
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code C09BA05
Medicinal product marketed in the Croatia Da
SmPC download
PL download

Packaging

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od nemelanomskog raka kože povezanog s primjenom hidroklorotiazida 17.10.2018 Alkaloid, Belupo, Berlin-Chemie Menarini, Boehringer Ingelheim International, Farmal, Genericon, Pharma, Jadran Galenski laboratorij, Krka - farma, Merck, Merck Sharp & Dohme, Novartis, PharmaSwiss, Pliva, Sandoz, sanofi-aventis i Stada
Back